ClinicalTrials.govpublic full text
Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder
chronic myeloproliferative disorders, graft versus host disease, leukemia, myelodysplastic syndromes, myelodysplastic/myeloproliferative diseases, polycythemia vera, chronic idiopathic myelofibrosis, essential thrombocythemia, untreated adult acute myeloid leukemia, recurrent adult acute myeloid leukemia, recurrent childhood acute myeloid leukemia, untreated childhood acute myeloid leukemia and other myeloid malignancies
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 831631
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.